Activated protein C: A potential therapeutic target of post-stroke epileptogenesis
- 18 January 2025
- journal article
- editorial
- Published by Elsevier in Epilepsy & Behavior
- Vol. 164, 110233
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Outcomes in Patients With Poststroke SeizuresJAMA Neurology, 2023
- International Post Stroke Epilepsy Research Consortium (IPSERC): A consortium to accelerate discoveries in preventing epileptogenesis after strokeEpilepsy & Behavior, 2022
- Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein CJournal of Experimental Medicine, 2021
- Epilepsy in older peopleThe Lancet, 2020
- 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in miceJournal of Experimental Medicine, 2019
- Activated protein C, protease activated receptor 1, and neuroprotectionBlood, 2018
- Activated protein C: biased for translationBlood, 2015
- Epilepsy biomarkersEpilepsia, 2013
- The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemiaProceedings of the National Academy of Sciences, 2003
- Anti-Inflammatory, Antithrombotic, and Neuroprotective Effects of Activated Protein C in a Murine Model of Focal Ischemic StrokeCirculation, 2001